Therapeutic Exposures and Risk Factors in MRONJ

Launched by MARMARA UNIVERSITY · May 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a condition called medication-related osteonecrosis of the jaw (MRONJ), which can happen after using certain medications. The goal of the study is to observe patients who have this condition over time to learn more about how they are diagnosed, treated, and monitored. Researchers want to find out how factors like a patient’s background, lifestyle, and other health issues might affect their recovery and quality of life.

To participate in this trial, individuals must be 18 years or older and seeking treatment for MRONJ at the Marmara University Faculty of Dentistry. Both men and women can join, as long as they or their legal representatives provide written consent. Participants can expect to be closely monitored during the study, allowing researchers to gather important information that could help improve care for others with this condition in the future. It’s important to note that this study is not open to individuals with other types of jaw issues not related to medication, or those under 18 years of age.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals aged 18 and over
• • Male or female individuals
• • Individuals who apply to the Marmara University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery due to medication-related osteonecrosis of jaw during the study period
• • Individuals or their legal representatives who have given written consent to participate in the study
• Exclusion Criteria:
• • Non-drug-related osteonecrosis/osteomyelitis
• • Osteoradionecrosis
• • Metastasis to the oral region
• • Individuals who have not given written consent to participate in the study
• • Individuals under the age of 18

Trial Officials